期刊文献+

乳杆菌活菌制剂在老年性阴道炎治疗中的作用

The Role of Lactobacillus in the Treatment of Senile Vaginitis
下载PDF
导出
摘要 目的:探讨乳杆菌活菌制剂治疗老年性阴道炎的临床疗效。方法选择老年性阴道炎患者120人,随机分为三组。治疗Ⅰ组、治疗Ⅱ组、治疗Ⅲ组,分别于疗前,疗后停药3~7天观察指标,进行统计学分析。结果三组比较,乳杆菌活菌制剂治疗组总有效率最高,并且助于阴道内乳杆菌的重建,提高阴道内雌激素水平。结论乳杆菌活菌制剂对老年性阴道炎有较好的治疗作用。 Objective To investigate the lactobacillus preparations for treatment of senile vaginitis clinical efifcacy.Methods 120 patients with senile vaginitis were randomly divided into three groups. Treatment groupⅠ, Ⅱ group therapy, treatmentⅢ group, respectively, before treatment, after treatment discontinuation 3~7 days observed indicators, statistical analysis.ResultsThe three groups, lactobacillus preparations highest total efifciency of the treatment group, and help rebuild the vaginal lactobacilli, improving vaginal estrogen levels.Conclusion Lactobacillus preparation on senile vaginitis have a better therapeutic effect.
作者 肖立英
出处 《中国继续医学教育》 2015年第14期157-158,共2页 China Continuing Medical Education
关键词 乳杆菌活菌制剂 老年性阴道炎 雌激素 Lactobacillus preparations Vaginitis Estrogen
  • 相关文献

参考文献3

二级参考文献34

  • 1杨冬梓,邝健全,梁贵尚.幼女外阴阴道炎临床分析[J].中华妇产科杂志,1995,30(3):170-171. 被引量:22
  • 2何世荣 李增碧 等.老年性阴道炎的研究--II、患者的阴道菌群、血浆女性激素水平和阴道pH值的检测[J].第三军医大学学报,1983,5(3):191-191. 被引量:1
  • 3闻良珍.妇产科领域厌氧菌感染的诊断和治疗[J].实用妇科与产科杂志,1988,4(6):321-321. 被引量:3
  • 4王宜玲 林英培 等.老年性阴道炎妇女的阴道生理功能改变[J].武汉医学杂志,1987,11(1):17-17. 被引量:1
  • 5何宜玲 林英培 等.老年性阴道炎的研究--I、老年性阴道炎患者阴道需氧菌菌群、阴道pH的检测和S.V.乳剂的疗效观察[J].第三军医大学学报,1983,5(2):102-102. 被引量:1
  • 6[1]Valerie B, Emily B, G illian R. Evidence from randomised trials on the longterm effects of hormone replacement therapy. Lancet,2002,360: 942-944. 被引量:1
  • 7[2]Troisi RJ, Cowie CC, Harris M. Hormone replacement therapy and glucose metabolism. Obstet Gynecol,2000,96:665-670. 被引量:1
  • 8[3]Ferera M,Petrie JR,Hillier C,et al. Hormone replacement therapy can argument vascular relaxation in postmenopausal women with type 2 diabetes.Hum Reprod,2002,23:1731-1736. 被引量:1
  • 9[4]Grodstein F, Stampfer MJ, Falkeborn M, et al. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology, 1999,10(5) :476-280. 被引量:1
  • 10[5]Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.JAMA, 1998,280: 321-333. 被引量:1

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部